Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 7, 2013

View Archived Issues

KaloBios Pharmaceuticals prepares novel monoclonal antibodies for COPD

FDA grants second fast track designation for MABp1

Data from genome-wide association study in patients with anemia published

Computational integration of schizophrenia-related genomics uncovers functional gene networks

Novel candidate antidiabetic drugs patented by Ajinomoto

Roche presents new TaR-1 ligands

Novel HIV vaccine adjuvants created by French investigators

Arena Pharmaceuticals prepares new GPR119 receptor ligands

Researchers study novel PRMT5 inhibitors for the treatment of beta-thalassemia and SCD

FDA grants QIDP designation to Paratek Pharmaceuticals' omadacycline

FDA clears IND for TGR-1202 studies

Kyowa Hakko Kirin advances second oncology candidate under agreement with Dicerna

Immunovaccine reports preclinical data on DepoVax-based anthrax vaccines

Investigators develop mouse model for evaluation of anti-human CD37 therapeutics

Philogen enters into worldwide licensing agreement with Pfizer for Dekavil

Savant obtains NIDA funding for preclinical development of 18-MC

Development of a low-cost, large-scale, multiplex-targeted, candidate gene mutation screen

FDA clears IND to investigate OrbeShield in GI-ARS

Receptos commences patient dosing in phase II trial of RPC-1063 in ulcerative colitis

Phase II trial of RM-493 for treatment of obesity begins

Data suggest 12-mg Proellex-V dose optimal for uterine fibroid treatment

Proteon Therapeutics reports results from study of recombinant human elastase

Bayer files application in Japan for use of VEGF TrapEye in macular edema following CRVO

iCo Therapeutics provides update on phase II iCo-007 trial

Biogen Idec files BLA for long-lasting factor IX therapy for hemophilia B

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...